Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma
Osteosarcoma is the most common primary malignant bone tumor with a high metastatic potential. Nowadays, there is a lack of new markers to identify prognosis of osteosarcoma patients with response to medical treatment. Recent studies have shown that hematological markers can reflect to some extent t...
Main Authors: | Longqing Li, Yang Wang, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Taojun Gong, Qing Chang, Jingqi Lin, Chuang Liu, Yi Luo, Li Min, Yong Zhou, Chongqi Tu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.879560/full |
Similar Items
-
A Nutritional Metabolism Related Prognostic Scoring System for Patients With Newly Diagnosed Osteosarcoma
by: Longqing Li, et al.
Published: (2022-04-01) -
The combination of baseline neutrophil to lymphocyte ratio and dynamic changes during treatment can better predict the survival of osteosarcoma patients
by: Longqing Li, et al.
Published: (2023-11-01) -
Osteosarcoma immune prognostic index can indicate the nature of indeterminate pulmonary nodules and predict the metachronous metastasis in osteosarcoma patients
by: Xuanhong He, et al.
Published: (2022-07-01) -
Prognostic significance of modified lung immune prognostic index in osteosarcoma patients
by: Xuanhong He, et al.
Published: (2022-10-01) -
Revision for Solid‐Body Breakage of the 3D‐Printed Implant Following Joint‐Sparing Surgery: A Technical Note
by: Zhuangzhuang Li, et al.
Published: (2024-04-01)